annual accounts payable:
$6.72M-$2.47M(-26.86%)Summary
- As of today (June 29, 2025), IBRX annual accounts payable is $6.72 million, with the most recent change of -$2.47 million (-26.86%) on December 31, 2024.
- During the last 3 years, IBRX annual accounts payable has fallen by -$4.69 million (-41.10%).
- IBRX annual accounts payable is now -68.00% below its all-time high of $21.02 million, reached on December 31, 2022.
Performance
IBRX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$13.50M+$6.78M(+100.76%)Summary
- As of today (June 29, 2025), IBRX quarterly accounts payable is $13.50 million, with the most recent change of +$6.78 million (+100.76%) on March 31, 2025.
- Over the past year, IBRX quarterly accounts payable has dropped by -$368.00 thousand (-2.65%).
- IBRX quarterly accounts payable is now -59.79% below its all-time high of $33.57 million, reached on March 31, 2023.
Performance
IBRX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IBRX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.9% | -2.6% |
| 3 y3 years | -41.1% | +37.3% |
| 5 y5 years | - | - |
IBRX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.0% | at low | -59.8% | +100.8% |
| 5 y | 5-year | -68.0% | at low | -59.8% | +100.8% |
| alltime | all time | -68.0% | at low | -59.8% | +100.8% |
IBRX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $13.50M(+100.8%) |
| Dec 2024 | $6.72M(-26.9%) | $6.72M(-32.4%) |
| Sep 2024 | - | $9.95M(-51.1%) |
| Jun 2024 | - | $20.32M(+46.5%) |
| Mar 2024 | - | $13.87M(+50.8%) |
| Dec 2023 | $9.20M(-56.2%) | $9.20M(-53.6%) |
| Sep 2023 | - | $19.82M(-22.2%) |
| Jun 2023 | - | $25.49M(-24.1%) |
| Mar 2023 | - | $33.57M(+59.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $21.02M(+84.1%) | $21.02M(+3.8%) |
| Sep 2022 | - | $20.24M(+12.1%) |
| Jun 2022 | - | $18.05M(+83.6%) |
| Mar 2022 | - | $9.83M(-13.9%) |
| Dec 2021 | $11.42M(-0.8%) | $11.42M(-24.5%) |
| Sep 2021 | - | $15.12M(-21.1%) |
| Jun 2021 | - | $19.15M(-4.7%) |
| Mar 2021 | - | $20.10M(+74.6%) |
| Dec 2020 | $11.51M | $11.51M |
FAQ
- What is ImmunityBio annual accounts payable?
- What is the all time high annual accounts payable for ImmunityBio?
- What is ImmunityBio annual accounts payable year-on-year change?
- What is ImmunityBio quarterly accounts payable?
- What is the all time high quarterly accounts payable for ImmunityBio?
- What is ImmunityBio quarterly accounts payable year-on-year change?
What is ImmunityBio annual accounts payable?
The current annual accounts payable of IBRX is $6.72M
What is the all time high annual accounts payable for ImmunityBio?
ImmunityBio all-time high annual accounts payable is $21.02M
What is ImmunityBio annual accounts payable year-on-year change?
Over the past year, IBRX annual accounts payable has changed by -$2.47M (-26.86%)
What is ImmunityBio quarterly accounts payable?
The current quarterly accounts payable of IBRX is $13.50M
What is the all time high quarterly accounts payable for ImmunityBio?
ImmunityBio all-time high quarterly accounts payable is $33.57M
What is ImmunityBio quarterly accounts payable year-on-year change?
Over the past year, IBRX quarterly accounts payable has changed by -$368.00K (-2.65%)